In the BioHarmony Drug Report Database
Amitiza (lubiprostone) is a small molecule pharmaceutical. Lubiprostone was first approved as Amitiza on 2006-01-31. It is used to treat constipation and irritable bowel syndrome in the USA. The pharmaceutical is active against chloride channel protein 2. Amitiza’s patents are valid until 2027-10-25 (FDA).
Image (chem structure or protein)